Enginzyme

• Valquest co invested in a SEK 75 million series B round to contribute to Enginzyme shift from R&D to a commercially driven company.

• EnginZyme is a Swedish biotechnology company developing a cell-free biomanufacturing platform that uses immobilized enzymes to produce chemicals more efficiently and sustainably. Its technology enables continuous enzymatic processes, combining the precision of biocatalysis with industrial scalability.